LDAH/C2orf43 Antikörper (AA 7-281) (APC)
Kurzübersicht für LDAH/C2orf43 Antikörper (AA 7-281) (APC) (ABIN8006302)
Target
Alle LDAH/C2orf43 (LDAH) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 7-281
-
Verwendungszweck
- Anti-LDAH Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human LDAH recombinant protein (Position: E7-D281).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- LDAH/C2orf43 (LDAH) (Lipid Droplet-Associated Hydrolase (LDAH))
-
Andere Bezeichnung
- LDAH
-
Hintergrund
-
Background: Serine lipid hydrolase associated with lipid droplets. Highly expressed in macrophage-rich areas in atherosclerotic lesions, suggesting that it could promote cholesterol ester turnover in macrophages.
Gene Full Name: lipid droplet associated hydrolase
-
Gen-ID
- 60526
-
UniProt
- Q9H6V9
Target
-